VERNON SUTTON to Genetic Testing
This is a "connection" page, showing publications VERNON SUTTON has written about Genetic Testing.
Connection Strength
1.920
-
Aicardi syndrome, an unsolved mystery: Review of diagnostic features, previous attempts, and future opportunities for genetic examination. Am J Med Genet C Semin Med Genet. 2018 12; 178(4):423-431.
Score: 0.404
-
Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr Opin Pediatr. 2016 12; 28(6):694-699.
Score: 0.351
-
Disorders of sexual development. Clin Perinatol. 2015 Jun; 42(2):395-412, ix-x.
Score: 0.312
-
Referring patients for a medical genetics consultation and genetic counseling. Adv Otorhinolaryngol. 2011; 70:25-27.
Score: 0.235
-
Tay-Sachs disease screening and counseling families at risk for metabolic disease. Obstet Gynecol Clin North Am. 2002 Jun; 29(2):287-96.
Score: 0.128
-
Reanalysis of Clinical Exome Sequencing Data. N Engl J Med. 2019 06 20; 380(25):2478-2480.
Score: 0.105
-
The ethics of conducting molecular autopsies in cases of sudden death in the young. Genome Res. 2016 09; 26(9):1165-9.
Score: 0.085
-
Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med. 2016 07; 18(7):678-85.
Score: 0.082
-
ACMG Policy Statement. Risk categorization for oversight of laboratory-developed tests for inherited conditions. Genet Med. 2013 Apr; 15(4):314-5.
Score: 0.067
-
Ethical and legal implications of genetic testing in androgen insensitivity syndrome. J Pediatr. 2007 Apr; 150(4):434-8.
Score: 0.045
-
Newborn screening and prenatal diagnosis for Rett syndrome: implications for therapy. J Child Neurol. 2005 Sep; 20(9):779-83.
Score: 0.040
-
Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020 06; 22(6):983-985.
Score: 0.027
-
De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations. Am J Hum Genet. 2016 Feb 04; 98(2):373-81.
Score: 0.021
-
Next-generation sequencing for disorders of low and high bone mineral density. Osteoporos Int. 2013 Aug; 24(8):2253-9.
Score: 0.017